U.S. federal trademark · Serial No. 97855551
pharmaceutical products for the treatment of hematologic cancers; pharmaceuticals for treatment of a myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, which is also known as acute myelogenous leukemia and acute nonlymphocytic leukemia
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.